Linked Data API

Show Search Form

Search Results

800571
star this property registered interest false more like this
star this property date less than 2017-12-04more like thismore than 2017-12-04
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
unstar this property answering dept sort name Health more like this
star this property hansard heading Neuromuscular Disorders more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what assessment he has made of the (a) extent and (b) effect on patient care of variation in specialist services for multiple sclerosis and Parkinson's among clinical commissioning groups in England. more like this
star this property tabling member constituency York Outer more like this
star this property tabling member printed
Julian Sturdy more like this
star this property uin 117192 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2017-12-12more like thismore than 2017-12-12
star this property answer text <p>We know that variation exists between clinical commissioning groups (CCGs) in the provision of care for neurological conditions, such as Parkinson’s disease and multiple sclerosis. Whilst it is right that CCGs have autonomy to shape services for local populations, there is a range of work ongoing at a national level to identify unwarranted variation in order to drive improvement, including:</p><p> </p><p>- Through the RightCare programme, which was rolled out to every CCG in 2016/17, NHS England provides practical support to commissioners to tackle unwarranted variation and identify improvements and savings, including for neurological services;</p><p>- Public Health England’s Neurology intelligence network collates and interprets data on adult neurological conditions to provide intelligence for the National Health Service, policy makers, and clinicians; and</p><p>- The Getting it Right First Time programme, supported by NHS Improvement, expanded earlier in 2017 to include neurology and will soon provide insight to demonstrate the value of better neurological services both in hospitals and in the community.</p><p> </p><p>NHS England will continue to work with the Neurological Alliance (an umbrella organisation for neurological condition charities) to support the new national Neurology Advisory Group (NAG), led by consultant neurologist Professor Adrian Williams. The NAG brings together system partners, professional bodies stakeholders to align work to improve neurological care, and has working to understand how best to utilise new and emerging data in services and outcomes. More information on national initiatives to reduce unwarranted variation and drive improvement can be found at the following links:</p><p> </p><p><a href="http://www.england.nhs.uk/rightcare/" target="_blank">www.england.nhs.uk/rightcare/</a></p><p> </p><p><a href="http://www.gov.uk/guidance/neurology-data-and-analysis-a-guide-for-health-professionals" target="_blank">www.gov.uk/guidance/neurology-data-and-analysis-a-guide-for-health-professionals</a></p><p> </p><p><a href="http://gettingitrightfirsttime.co.uk/" target="_blank">gettingitrightfirsttime.co.uk/</a></p>
star this property answering member constituency Winchester more like this
unstar this property answering member printed Steve Brine remove filter
star this property grouped question UIN 117193 more like this
star this property question first answered
less than 2017-12-12T17:07:27.203Zmore like thismore than 2017-12-12T17:07:27.203Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
4079
unstar this property label Biography information for Julian Sturdy more like this
800572
star this property registered interest false more like this
star this property date less than 2017-12-04more like thismore than 2017-12-04
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
unstar this property answering dept sort name Health more like this
star this property hansard heading Neuromuscular Disorders more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what assessment his Department has made of the potential for improved specialist services for multiple sclerosis and Parkinson's delivering significant savings for the NHS; and if he will make a statement. more like this
star this property tabling member constituency York Outer more like this
star this property tabling member printed
Julian Sturdy more like this
star this property uin 117193 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2017-12-12more like thismore than 2017-12-12
star this property answer text <p>We know that variation exists between clinical commissioning groups (CCGs) in the provision of care for neurological conditions, such as Parkinson’s disease and multiple sclerosis. Whilst it is right that CCGs have autonomy to shape services for local populations, there is a range of work ongoing at a national level to identify unwarranted variation in order to drive improvement, including:</p><p> </p><p>- Through the RightCare programme, which was rolled out to every CCG in 2016/17, NHS England provides practical support to commissioners to tackle unwarranted variation and identify improvements and savings, including for neurological services;</p><p>- Public Health England’s Neurology intelligence network collates and interprets data on adult neurological conditions to provide intelligence for the National Health Service, policy makers, and clinicians; and</p><p>- The Getting it Right First Time programme, supported by NHS Improvement, expanded earlier in 2017 to include neurology and will soon provide insight to demonstrate the value of better neurological services both in hospitals and in the community.</p><p> </p><p>NHS England will continue to work with the Neurological Alliance (an umbrella organisation for neurological condition charities) to support the new national Neurology Advisory Group (NAG), led by consultant neurologist Professor Adrian Williams. The NAG brings together system partners, professional bodies stakeholders to align work to improve neurological care, and has working to understand how best to utilise new and emerging data in services and outcomes. More information on national initiatives to reduce unwarranted variation and drive improvement can be found at the following links:</p><p> </p><p><a href="http://www.england.nhs.uk/rightcare/" target="_blank">www.england.nhs.uk/rightcare/</a></p><p> </p><p><a href="http://www.gov.uk/guidance/neurology-data-and-analysis-a-guide-for-health-professionals" target="_blank">www.gov.uk/guidance/neurology-data-and-analysis-a-guide-for-health-professionals</a></p><p> </p><p><a href="http://gettingitrightfirsttime.co.uk/" target="_blank">gettingitrightfirsttime.co.uk/</a></p>
star this property answering member constituency Winchester more like this
unstar this property answering member printed Steve Brine remove filter
star this property grouped question UIN 117192 more like this
star this property question first answered
remove maximum value filtermore like thismore than 2017-12-12T17:07:27.25Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
4079
unstar this property label Biography information for Julian Sturdy more like this
790978
star this property registered interest false more like this
star this property date less than 2017-11-16more like thismore than 2017-11-16
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
unstar this property answering dept sort name Health more like this
star this property hansard heading General Practitioners: Pharmacy more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what the process is for payment of general practitioners dealing with NHS prescriptions. more like this
star this property tabling member constituency Wrexham more like this
star this property tabling member printed
Ian C. Lucas more like this
star this property uin 113530 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2017-11-21more like thismore than 2017-11-21
star this property answer text <p>Where general practitioners (GPs) write a prescription which is dispensed in the practice, or provide a drug or medicine which is immediately necessary, the practice is reimbursed under provisions set out in the Statement of Financial Entitlements (SFE).</p><p> </p><p>Once dispensed, prescriptions are sent to the NHS Business Services Authority (NHS BSA) with a claim for payment. The SFE requires NHS England to make a payment, at the beginning of the month following the claim, equal to 80% of the estimated amount due to the GP practice. Once the claim has been verified by the NHS BSA, they will advise NHS England who then pay the balance of the amount due.</p><p> </p><p>Payments to GPs for dispensing drugs include the basic price of the drug, an appropriate dispensing fee and an allowance to cover the VAT payable on the purchase of any drugs or medicines which are personally administered.</p> more like this
star this property answering member constituency Winchester more like this
unstar this property answering member printed Steve Brine remove filter
star this property question first answered
less than 2017-11-21T14:40:45.753Zmore like thisremove minimum value filter
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
1470
unstar this property label Biography information for Ian C. Lucas more like this
790979
star this property registered interest false more like this
star this property date less than 2017-11-16more like thismore than 2017-11-16
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
unstar this property answering dept sort name Health more like this
star this property hansard heading Health Services and Social Services: Wolverhampton City Council more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what recent discussions he has had with Wolverhampton City Council on the provision of health and social care. more like this
star this property tabling member constituency Wolverhampton North East more like this
star this property tabling member printed
Emma Reynolds more like this
star this property uin 113536 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2017-11-21more like thismore than 2017-11-21
star this property answer text <p>The Department has had no recent discussions specifically with Wolverhampton City Council on the provision of health and social care.</p><p> </p><p>The West Midlands Combined Authority, which includes Wolverhampton, has had discussions with the Government on a range of issues including health and social care.</p><p> </p><p>Wolverhampton City Council should be involved in discussion around the provision of health and social care as part of the wider Black Country Sustainability and Transformation Partnership (STP). NHS England holds regular discussions with all STP leaders.</p> more like this
star this property answering member constituency Winchester more like this
unstar this property answering member printed Steve Brine remove filter
star this property question first answered
less than 2017-11-21T14:42:48.733Zmore like thismore than 2017-11-21T14:42:48.733Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
4077
unstar this property label Biography information for Emma Reynolds more like this
795888
star this property registered interest false more like this
star this property date less than 2017-11-28more like thismore than 2017-11-28
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
unstar this property answering dept sort name Health more like this
star this property hansard heading General Practitioners: Essex more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, how many patients are registered with each General Practitioner in each Clinical Commissioning Group area in Essex. more like this
star this property tabling member constituency Witham more like this
star this property tabling member printed
Priti Patel more like this
star this property uin 116214 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2017-12-06more like thismore than 2017-12-06
star this property answer text <p>Since 2004 general practitioners (GPs) no longer hold an individual list of registered patients as patients now register with a practice.</p><p> </p><p>Data for the number of general practitioners (headcount) working in each clinical commissioning group (CCG) in Essex, and the number of patients registered at each CCG is set out below. General practitioner headcount figures include GP Providers, Salaried GPs, Registrars, Retainers and Locums.</p><p> </p><table><tbody><tr><td><p>CCG Name</p></td><td><p>All GP Headcount <br> at 30 September 2017</p></td><td><p>Number of registered patients at 1 October 2017</p></td><td><p>Average number of patients per GP</p></td></tr><tr><td><p>NHS Mid Essex CCG</p></td><td><p>219</p></td><td><p>390,061</p></td><td><p>1,781</p></td></tr><tr><td><p>NHS North East Essex CCG</p></td><td><p>181</p></td><td><p>348,600</p></td><td><p>1,926</p></td></tr><tr><td><p>NHS Thurrock CCG</p></td><td><p>84</p></td><td><p>175,112</p></td><td><p>2,085</p></td></tr><tr><td><p>NHS West Essex CCG</p></td><td><p>201</p></td><td><p>311,063</p></td><td><p>1, 548</p></td></tr><tr><td><p>NHS Basildon and Brentwood CCG</p></td><td><p>146</p></td><td><p>277,607</p></td><td><p>1, 901</p></td></tr><tr><td><p>NHS Castle Point and Rochford CCG</p></td><td><p>101</p></td><td><p>184,834</p></td><td><p>1, 830</p></td></tr><tr><td><p>NHS Southend CCG</p></td><td><p>143</p></td><td><p>188,009</p></td><td><p>1, 315</p></td></tr></tbody></table>
star this property answering member constituency Winchester more like this
unstar this property answering member printed Steve Brine remove filter
star this property question first answered
less than 2017-12-06T12:43:30.51Zmore like thismore than 2017-12-06T12:43:30.51Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
4066
unstar this property label Biography information for Priti Patel more like this
792993
star this property registered interest false more like this
star this property date less than 2017-11-21more like thismore than 2017-11-21
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
unstar this property answering dept sort name Health more like this
star this property hansard heading Radiotherapy more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, in which ten areas of England do residents have the longest travel times to their nearest radiotherapy units. more like this
star this property tabling member constituency Westmorland and Lonsdale more like this
star this property tabling member printed
Tim Farron more like this
star this property uin 114778 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2017-11-29more like thismore than 2017-11-29
star this property answer text <p>This information is not held centrally.</p><p> </p><p>Public Health England advises that a postcode-level dataset that will enable the calculation of travel times to radiotherapy units is currently in development by the National Cancer Registry and Analysis Service. Results will be published in 2018.</p> more like this
star this property answering member constituency Winchester more like this
unstar this property answering member printed Steve Brine remove filter
star this property question first answered
less than 2017-11-29T17:14:42.007Zmore like thismore than 2017-11-29T17:14:42.007Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
1591
unstar this property label Biography information for Tim Farron more like this
795328
star this property registered interest false more like this
star this property date less than 2017-11-27more like thismore than 2017-11-27
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
unstar this property answering dept sort name Health more like this
star this property hansard heading Fentanyl more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health what steps his Department is taking to ensure that the pain management of cancer and palliative care patients will not be affected by proposals to restrict the prescription of fentanyl. more like this
star this property tabling member constituency West Lancashire more like this
star this property tabling member printed
Rosie Cooper more like this
star this property uin 115749 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2017-12-05more like thismore than 2017-12-05
star this property answer text <p>NHS England held a three month consultation between July and October 2017 on draft guidance for clinical commissioning groups (CCGs) on a range of ‘items that should not routinely be prescribed in primary care’. This included immediate release fentanyl.</p><p> </p><p>At the end of November, the NHS England Board considered the responses received and evidence submitted during the three month public consultation, which closed on 21 October, and the content of final statutory guidance to CCGs. The three recommendations covering immediate release fentanyl which have been agreed are:</p><p> </p><p>- Advise CCGs that prescribers in primary care should not initiate immediate release fentanyl for any new patient;</p><p>- Advise CCGs to support prescribers in deprescribing immediate release fentanyl in all patients and, where appropriate, ensure the availability of relevant services to facilitate this change; and</p><p>- Advise CCGs that if, in exceptional circumstances, there is a clinical need for immediate release fentanyl to be prescribed in primary care, this should be undertaken in a cooperation arrangement with a multi-disciplinary team and/or other healthcare professional.</p><p> </p><p>However, these recommendations do not apply to patients undergoing palliative care treatment and where the recommendation to use immediate release fentanyl in line with the National Institute for Health and Care Excellence guidance, has been made by a multidisciplinary team and/or other healthcare professional with a recognised specialism in palliative care.</p><p> </p><p>‘Items which should not be routinely prescribed in primary care: Guidance for CCGs’ has now been published and more information can be found here:</p><p><a href="https://www.england.nhs.uk/medicines/items-which-should-not-be-routinely-prescribed/" target="_blank">https://www.england.nhs.uk/medicines/items-which-should-not-be-routinely-prescribed/</a></p>
star this property answering member constituency Winchester more like this
unstar this property answering member printed Steve Brine remove filter
star this property question first answered
less than 2017-12-05T16:48:32.36Zmore like thismore than 2017-12-05T16:48:32.36Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
1538
unstar this property label Biography information for Rosie Cooper more like this
795330
star this property registered interest false more like this
star this property date less than 2017-11-27more like thismore than 2017-11-27
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
unstar this property answering dept sort name Health more like this
star this property hansard heading Fentanyl more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health which (a) cancer and (b) palliative care specialists were consulted on the development of NHS England proposals to restrict the prescription of fentanyl for cancer and palliative care patients. more like this
star this property tabling member constituency West Lancashire more like this
star this property tabling member printed
Rosie Cooper more like this
star this property uin 115751 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2017-12-05more like thismore than 2017-12-05
star this property answer text <p>A number of engagement meetings and events were held during the consultation to ensure that health professionals, patients, their families and carers had an opportunity to share their views and expertise on the proposals. This included two targeted meetings about immediate release fentanyl with health professionals, charities and patient groups from end of life care and chronic pain networks. A round table briefing session for hon. Members, Lords and researchers was also held on 11 October where clear views were heard on this matter from parliamentarians, including Baroness Finlay, a palliative care specialist. A number of responses were also received from specialist organisations in this field including: Marie Curie, local palliative and end of life care managed clinical networks, the National Institute for Health and Care Excellence, Hospice UK and Leukaemia Care.</p> more like this
star this property answering member constituency Winchester more like this
unstar this property answering member printed Steve Brine remove filter
star this property question first answered
less than 2017-12-05T16:36:02.02Zmore like thismore than 2017-12-05T16:36:02.02Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
1538
unstar this property label Biography information for Rosie Cooper more like this
798674
star this property registered interest false more like this
star this property date less than 2017-12-01more like thismore than 2017-12-01
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
unstar this property answering dept sort name Health more like this
star this property hansard heading Breast Cancer: Biosimilar Medicines more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what discussions NHS England has had with (a) breast cancer charities and (b) patient groups on the introduction of the biosimilars of Herceptin, Trastuzumab. more like this
star this property tabling member constituency West Ham more like this
star this property tabling member printed
Lyn Brown more like this
star this property uin 117068 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2017-12-11more like thismore than 2017-12-11
star this property answer text <p>NHS England is working closely with the Cancer Vanguard and the Chemotherapy Clinical Reference Group to ensure all stakeholders, including charities and patient groups, are involved with the implementation of biosimilar trastuzumab.</p> more like this
star this property answering member constituency Winchester more like this
unstar this property answering member printed Steve Brine remove filter
star this property question first answered
less than 2017-12-11T17:46:07.797Zmore like thismore than 2017-12-11T17:46:07.797Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
1583
unstar this property label Biography information for Lyn Brown more like this
797931
star this property registered interest false more like this
star this property date less than 2017-11-30more like thismore than 2017-11-30
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
unstar this property answering dept sort name Health more like this
star this property hansard heading Drugs: Research more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what assessment he has made of the effect of decreasing NHS spending on pharmaceuticals on the attractiveness of the UK as a location for research and development. more like this
star this property tabling member constituency Wellingborough more like this
star this property tabling member printed
Mr Peter Bone more like this
star this property uin 116838 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2017-12-05more like thismore than 2017-12-05
star this property answer text <p>The most important attraction for companies considering investing in research in the United Kingdom is the availability of world-class scientific expertise, which is the focus of the Government’s effort to ensure the UK remains at the forefront of global research and development. There is no obvious reason why National Health Service spend on pharmaceuticals should significantly affect decisions to invest in research and development in the UK. NHS spending on pharmaceuticals has risen by 41% between 2007/08 and 2016/17.</p> more like this
star this property answering member constituency Winchester more like this
unstar this property answering member printed Steve Brine remove filter
star this property question first answered
less than 2017-12-05T16:43:53.71Zmore like thismore than 2017-12-05T16:43:53.71Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
1581
unstar this property label Biography information for Mr Peter Bone more like this